Compare VNDA & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNDA | AIV |
|---|---|---|
| Founded | 2002 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.9M | 435.9M |
| IPO Year | 2005 | 1996 |
| Metric | VNDA | AIV |
|---|---|---|
| Price | $5.98 | $2.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $14.90 | $10.00 |
| AVG Volume (30 Days) | 923.7K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 87.41% |
| EPS Growth | N/A | ★ 616.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $216,105,000.00 | $138,486,000.00 |
| Revenue This Year | $21.35 | N/A |
| Revenue Next Year | $37.40 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $4.14 | $2.85 |
| 52 Week High | $9.91 | $8.87 |
| Indicator | VNDA | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 18.14 |
| Support Level | $5.85 | $2.85 |
| Resistance Level | $6.73 | $4.30 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 50.05 | 5.18 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment, and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development. Operating, and Other. The development segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. The operating segment includes residential apartments, communities with apartment homes that have achieved a stabilized level of operations. The other segment includes The Benson Hotel, the company's only hotel. The majority of revenue is gained from the Operating Segment.